Kymera Therapeutics Earnings
NASDAQ: KYMRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.25
Kymera Therapeutics earnings summary
Kymera Therapeutics is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-1.25. In its most recent report on Aug 5, 2026 (Q2 2026), KYMR posted EPS of $-0.62. Revenue for the quarter was $65.0 million.
Across the last 16 reports, KYMR shares moved an average of 5.3% (in either direction) in the first trading session after results, rising 13 times and falling 3 times.
Summary generated from market data by MetaCap's automated system. Methodology
KYMR earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-0.62 | — | +9.2% |
| Apr 30, 2026 | — | $-0.71 | — | +6.7% |
| Feb 26, 2026 | — | $-0.98 | — | -8.6% |
| Nov 4, 2025 | — | $-0.94 | — | +10.7% |
| Aug 11, 2025 | — | $-0.95 | — | +3.4% |
| May 9, 2025 | — | $-0.82 | — | +0.6% |
| Feb 27, 2025 | — | $-0.89 | — | +4.9% |
| Oct 31, 2024 | — | $-0.82 | — | +9.6% |
| Aug 7, 2024 | — | $-0.58 | — | +5.7% |
| May 2, 2024 | — | $-0.69 | — | +1.3% |
| Feb 22, 2024 | — | $-0.25 | — | +4.0% |
| Nov 2, 2023 | — | $-0.90 | — | +1.8% |
| Aug 3, 2023 | — | $-0.67 | — | -11.2% |
| May 4, 2023 | — | $-0.70 | — | -2.3% |
| Feb 23, 2023 | — | $-0.59 | — | +4.3% |
| Nov 3, 2022 | — | $-0.79 | — | +0.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.